Peptides are emerging as a new tool in drug and gene delivery. Peptide-drug conjugates
and peptide-modified drug delivery systems provide new opportunities to avoid macrophage …

Peptides are small biological molecules that are attractive in drug delivery and materials
engineering for applications including therapeutics, molecular building blocks and cell …

From the first clinical trial by Dr. WF Anderson to the most recent US Food and Drug
Administration–approved Luxturna (Spark Therapeutics, 2017) and Zolgensma (Novartis …

The diverse amino acid chemistries and secondary structures in peptides provide
'minimalist'mimics of motifs in proteins and offer many ideal properties for targeted delivery …

Nearly 30 years ago, certain small, relatively nontoxic peptides were discovered to be
capable of traversing the cell membrane. These cell-penetrating peptides, as they are now …

Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands
has made significant progress in recent years, both in regards to the structural design of the …

Utilizing peptides as therapeutic agents is considered an attractive approach for the
treatment of various diseases due to their high binding and selectivity to novel drug targets …

Introduction: Delivery of macromolecular drugs is an important field in medical research.
However, macromolecules are usually unable to cross the cell membrane without the …

The ability of cell-penetrating peptides to cross plasma membranes has been used for
various applications, including the delivery of bioactive molecules to inhibit disease …

Targeted drug delivery to specific group of cells offers an attractive strategy to minimize the
undesirable side effects and achieve the therapeutic effect with a lower dose. Both linear …